|
|
|
|
Institut für Kardiovaskuläre Physiologie, Johann Wolfgang v. Goethe-Universität, Frankfurt/Main, Germany
We analyzed whether the cyclic AMP induced down-regulation of the nitric oxide (NO) receptor soluble guanylyl cyclase (sGC) is mediated by the mRNA-protecting protein HuR. Exposure (up to 24 h) of isolated rat aortic segments to the activator of adenylyl cyclase, forskolin (10 µM), and to both activators of cAMP-stimulated protein kinase (PKA), 5,6-dichloro-1-
-D-ribofuranosylbenzimidazole-3',5'-cyclic monophosphorothioate, Spisomer (Sp-5,6-DCl-cBIMPS; 400 nM), and N6-phenyl-cAMP (10 µM), strongly reduced sGC
1
1 and HuR protein and mRNA expression in a time-dependent and actinomycin D (10 µM)-sensitive fashion. In vitro degradation of sGC
1 and
1 poly(A)+ mRNA by native rat aortic protein was markedly increased by pretreatment of intact aortas with forskolin. Native protein extract from rat aorta shifted the electrophoretic mobility of biotin-labeled riboprobes from the 3'-untranslated region of sGC
1 and
1 mRNA, and these bands was supershifted by a monoclonal antibody directed against the mRNA-stabilizing protein HuR. Forskolin decreased the HuR-sGC
1 and
1 mRNA interaction and HuR protein expression in rat aorta, and this was prevented by the PKA inhibitory cAMP analog 3',5'-cyclic monophosphorothioate, Rp-isomer (Rp-cAMPS). In cultured smooth muscle cells from rat aorta, forskolin induced a rapid increase in Fos/p-Fos protein levels and activator protein 1 (AP-1) binding activity. Inhibition of this transcription factor by an AP-1 decoy prevented the forskolin-induced down-regulation of HuR. We conclude that forskolin/cAMP decrease the expression of heterodimeric sGC in rat aortic smooth muscle cells via activation of Fos/AP-1, which decreases the expression of HuR and thus destabilizes the sGC
1 and
1 mRNA.
Address correspondence to: Stephan Kloess, Institut für Kardiovaskuläre Physiologie, Universität Frankfurt, Theodor-Stern-Kai 7, D-60590 Frankfurt. E-mail: s.kloess{at}em.uni-frankfurt.de
This article has been cited by other articles:
![]() |
I. G. Sharina, F. Jelen, E. P. Bogatenkova, A. Thomas, E. Martin, and F. Murad {alpha}1 Soluble Guanylyl Cyclase (sGC) Splice Forms as Potential Regulators of Human sGC Activity J. Biol. Chem., May 30, 2008; 283(22): 15104 - 15113. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Glynos, A. Kotanidou, S. E. Orfanos, Z. Zhou, D. C. M. Simoes, C. Magkou, C. Roussos, and A. Papapetropoulos Soluble guanylyl cyclase expression is reduced in LPS-induced lung injury Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1448 - R1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jiang and S. S Stojilkovic Molecular cloning and characterization of {alpha}1-soluble guanylyl cyclase gene promoter in rat pituitary cells J. Mol. Endocrinol., December 1, 2006; 37(3): 503 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jurado, F. Rodriguez-Pascual, J. Sanchez-Prieto, F. M. Reimunde, S. Lamas, and M. Torres NMDA induces post-transcriptional regulation of {alpha}2-guanylyl-cyclase-subunit expression in cerebellar granule cells J. Cell Sci., April 15, 2006; 119(8): 1622 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Krumenacker, A. Kots, and F. Murad Effects of the JNK inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP-600125) on soluble guanylyl cyclase {alpha}1 gene regulation and cGMP synthesis Am J Physiol Cell Physiol, October 1, 2005; 289(4): C778 - C784. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Wolin Loss of Vascular Regulation by Soluble Guanylate Cyclase Is Emerging as a Key Target of the Hypertensive Disease Process Hypertension, June 1, 2005; 45(6): 1068 - 1069. [Full Text] [PDF] |
||||
![]() |
S. Kloss, D. Rodenbach, R. Bordel, and A. Mulsch Human-Antigen R (HuR) Expression in Hypertension: Downregulation of the mRNA Stabilizing Protein HuR in Genetic Hypertension Hypertension, June 1, 2005; 45(6): 1200 - 1206. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Wickenheisser, V. L. Nelson-DeGrave, and J. M. McAllister Dysregulation of Cytochrome P450 17{alpha}-Hydroxylase Messenger Ribonucleic Acid Stability in Theca Cells Isolated from Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1720 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Browner, N. B. Dey, K. D. Bloch, and T. M. Lincoln Regulation of cGMP-dependent Protein Kinase Expression by Soluble Guanylyl Cyclase in Vascular Smooth Muscle Cells J. Biol. Chem., November 5, 2004; 279(45): 46631 - 46636. [Abstract] [Full Text] [PDF] |
||||